Business Description
Energenesis Biomedical Co Ltd
ISIN : TW0006657000
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 83.39 | |||||
Equity-to-Asset | 0.96 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.04 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 78.94 | |||||
Beneish M-Score | -2.22 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -2.3 | |||||
3-Year EBITDA Growth Rate | -13.3 | |||||
3-Year EPS without NRI Growth Rate | -12 | |||||
3-Year FCF Growth Rate | -15.5 | |||||
3-Year Book Growth Rate | -12.3 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 22.8 | |||||
9-Day RSI | 32.04 | |||||
14-Day RSI | 37.88 | |||||
6-1 Month Momentum % | 1.79 | |||||
12-1 Month Momentum % | -6.86 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 21.08 | |||||
Quick Ratio | 21.06 | |||||
Cash Ratio | 20.28 | |||||
Days Inventory | 157.43 | |||||
Days Sales Outstanding | 66.81 | |||||
Days Payable | 46.53 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.3 | |||||
Shareholder Yield % | -0.26 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 72.6 | |||||
Operating Margin % | -3890.67 | |||||
Net Margin % | -3516.26 | |||||
FCF Margin % | -3477.43 | |||||
ROE % | -24.14 | |||||
ROA % | -23.25 | |||||
ROIC % | -183.06 | |||||
ROC (Joel Greenblatt) % | -232.84 | |||||
ROCE % | -24 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 760.61 | |||||
PB Ratio | 6 | |||||
Price-to-Tangible-Book | 6.16 | |||||
EV-to-EBIT | -18.37 | |||||
EV-to-EBITDA | -20.28 | |||||
EV-to-Revenue | 645.3 | |||||
EV-to-FCF | -18.9 | |||||
Price-to-Net-Current-Asset-Value | 7.04 | |||||
Price-to-Net-Cash | 7.34 | |||||
Earnings Yield (Greenblatt) % | -5.44 | |||||
FCF Yield % | -4.62 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Energenesis Biomedical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 5.153 | ||
EPS (TTM) (NT$) | -2.349 | ||
Beta | 0.5 | ||
Volatility % | 22.28 | ||
14-Day RSI | 37.88 | ||
14-Day ATR (NT$) | 1.598171 | ||
20-Day SMA (NT$) | 53.80388 | ||
12-1 Month Momentum % | -6.86 | ||
52-Week Range (NT$) | 45.488196 - 63.326705 | ||
Shares Outstanding (Mil) | 77.19 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Energenesis Biomedical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Energenesis Biomedical Co Ltd Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
Energenesis Biomedical Co Ltd Frequently Asked Questions
What is Energenesis Biomedical Co Ltd(TPE:6657)'s stock price today?
When is next earnings date of Energenesis Biomedical Co Ltd(TPE:6657)?
Does Energenesis Biomedical Co Ltd(TPE:6657) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |